Abstract
The influence of sterol carrier protein-2 (SCP-2) on the cellular metabolism of sphingolipids was examined in control mouse L-cells and stably transfected clones expressing the protein SCP-2. Three approaches were used to examine for differences; (1) compositional analysis of endogenous sphingolipid classes, (2) metabolism of NBD-ceramide, and (3) live cell labelling via endocytic uptake of BODIPY-sphingomyelin. SCP-2 over expression significantly altered the endogenous levels of both neutral and acidic sphingolipid classes. Among the neutral sphingolipids, expression of SCP-2 induced a 1.7-fold increase in the level of lactosylceramide (LacCer, p < 0.05) and a similar fold decrease in the level of the higher-order neutral glycosylceramides (p < 0.05). Among the acidic sphingolipids, SCP-2 resulted in a 5.2-fold decrease in the endogenous plasma membrane level of ganglioside GM1 (p < 0.03). Incubation of both control and transfected cell lines with NBD-ceramide resulted in the rapid establishment of a steady-state distribution of NBD-labelled sphingomyelin (NBD-SM) and glucosylceramide (NBD-GlcCer). In the SCP-2 expressing clones the conversion of NBD-Cer to NBD-GlcCer was 30% lower during incubation periods between 5 and 30 min (p < 0.025). Inspection of the cells by fluorescence microscopy after incubation with BODIPY labelled sphingomyelin (BODIPY-SM) revealed similar punctuated patterns with no distinguishable differences between the cell types. These results imply that SCP-2 plays a role in modulating enzymatic steps involved in metabolism of sphingolipid homeostasis.
Similar content being viewed by others
Abbreviations
- SCP-2:
-
sterol carrier protein-2
- SAP:
-
sphingolipid activator protein
- BSA:
-
bovine serum albumin
- DF-BSA:
-
defatted BSA
- HMEM:
-
hepes buffered minimum essential media
- PBS:
-
phosphate buffered saline
- BODIPY:
-
boron dipyrromethenedi-fluoride
- NDB-:
-
N-[7-(4-nitrobenzo-2-oxa-1,2-diazole)]-6-aminocaproyl-, NDB-Cer, N-[7-(4-nitrobenzo-2-oxa-1,2-diazole)]-6-aminocaproyl-D-erythro-sphingosine
- Cer:
-
ceramide
- GlcCer:
-
glucosylceramide
- CoA:
-
co-enzyme A
- CGT:
-
ceramide glucosyltransferase
- Gal:
-
galactose
- GalCer:
-
galactosylceramide
- Glc:
-
glucose
- GlcCer:
-
glucosylceramide
- GSL:
-
glycosphingolipid
- LacCer:
-
lactosylceramide
- SL:
-
sphingolipid
- SM:
-
sphingomyelin
- TLC:
-
thin layer chromatography
References
Hannun YA, Bell RM: Functions of sphingolipids and sphingolipid breakdown products in cellular regulation. Science 243: 500–507, 1989
Ghosh S, Strum JC, Bell RM: Lipid biochemistry: Functions of glycerolipids and sphingolipids in cellular signaling. FASEB J 11: 45–50, 1997
Hakomori S: Structure, organization, and function of glycosphingolipids in membrane. Curr Opin Hematol 10: 16–24, 2003
Foster LJ, De Hoog CL, Mann M: Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors. Proc Natl Acad Sci U S A 100: 5813–5818, 2003
Sandvig K, van Deurs B: Endocytosis and intracellular transport of ricin: Recent discoveries. FEBS Lett 452: 67–70, 1999
Chazal NGD: Virus entry, assembly, budding, and membrane reafts. Microbiol Mol Biol Rev 226–237, 2003
Bavari S, Bosio CM, Wiegand E, Ruthel G, Will AB, Geisbert TW, Hevey M, Schmaljohn C, Schmaljohn A, Aman MJ: Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J Exp Med 195: 593–602, 2002
Empig CJ, Goldsmith MA: Association of the caveola vesicular system with cellular entry by filoviruses. J Virol 76: 5266–5270, 2002
Marjomaki V, Pietiainen V, Matilainen H, Upla P, Ivaska J, Nissinen L, Reunanen H, Huttunen P, Hyypia T, Heino J: Internalization of echovirus 1 in caveolae. J Virol 76: 1856–1865, 2002
Scheiffele P, Roth MG, Simons K: Interaction of influenza virus haemagglutinin with sphingolipid-cholesterol membrane domains via its transmembrane domain. EMBO J 16: 5501–5508, 1997
Marsh M, Pelchen-Matthews A: Endocytosis in viral replication. Traffic 1: 525–532, 2000
Sieczkarski SB, Whittaker GR: Dissecting virus entry via endocytosis. J Gen Virol 83: 1535–1545, 2002
Shin J-SaA, S.N.: Caveolae as portals of entry for microbes. Microbes and Infection 3: 755–761, 2002
Norkin LC: Caveolae in the uptake and targeting of infectious agents and secreted toxins. Adv Drug Deliv Rev 49: 301–315, 2001
Anderson RG, Jacobson K: A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains. Science 296: 1821–1825, 2002
Stolowich NJ, Petrescu AD, Huang H, Martin GG, Scott AI, Schroeder F: Sterol carrier protein-2: Structure reveals function. Cell Mol Life Sci 59: 193–212, 2002
Stolowich N, Frolov A, Petrescu AD, Scott AI, Billheimer JT, Schroeder F: Holo-sterol carrier protein-2. (13)C NMR investigation of cholesterol and fatty acid binding sites. J Biol Chem 274: 35425–35433, 1999
Schroeder F, Frolov A, Schoer, J, Gallegos A, Atshaves BP, Stolowich NJ, Scott AI, Kier AB: Intracellular cholesterol binding proteins, cholesterol transport and membrane domains. In: Freeman TYCaDA (ed) Intracellular Cholesterol Trafficking. Kluwer Academic Publishers, Boston, 1998, pp 213–234
Avdulov NA, Chochina SV, Igbavboa U, Warden CS, Schroeder F, Wood WG: Lipid binding to sterol carrier protein-2 is inhibited by ethanol. Biochim Biophys Acta 1437: 37–45, 1999
Schroeder F, Myers-Payne SC, Billheimer JT, Wood WG: Probing the ligand binding sites of fatty acid and sterol carrier proteins: effects of ethanol. Biochemistry 34: 11919–11927, 1995
Stolowich NJ, Frolov A, Atshaves B, Murphy EJ, Jolly CA, Billheimer JT, Scott AI, Schroeder F: The sterol carrier protein-2 fatty acid binding site: An NMR, circular dichroic, and fluorescence spectroscopic determination. Biochemistry 36: 1719–1729, 1997
Frolov A, Cho TH, Billheimer JT, Schroeder F: Sterol carrier protein-2, a new fatty acyl coenzyme A-binding protein. J Biol Chem 271: 31878–31884, 1996
Gallegos AM, Atshaves BP, Storey SM, Starodub O, Petrescu AD, Huang H, McIntosh AL, Martin GG, Chao H, Kier AB, Schroeder F: Gene structure, intracellular localization, and functional roles of sterol carrier protein-2. Prog Lipid Res 40: 498–563, 2001
Wirtz KW: Phospholipid transfer proteins revisited. Biochem J 324 (Pt 2): 353–360, 1997
Bloj B, Zilversmit DB: Rat liver proteins capable of transferring phosphatidylethanolamine. Purification and transfer activity for other phospholipids and cholesterol. J Biol Chem 252: 1613–1619, 1977
Bloj B, Zilversmit DB: Accelerated transfer of neutral glycosphingolipids and ganglioside GM1 by a purified lipid transfer protein. J Biol Chem 256: 5988–5991, 1981
Chao H, Zhou M, McIntosh A, Schroeder F, Kier AB: ACBP and cholesterol differentially alter fatty acyl CoA utilization by microsomal ACAT. J Lipid Res 44: 72–83, 2003
Starodub O, Jolly CA, Atshaves BP, Roths JB, Murphy EJ, Kier AB, Schroeder F: Sterol carrier protein-2 localization in endoplasmic reticulum and role in phospholipid formation. Am J Physiol Cell Physiol 279: C1259–1269, 2000
Moncecchi D, Murphy EJ, Prows DR, Schroeder F: Sterol carrier protein-2 expression in mouse L-cell fibroblasts alters cholesterol uptake. Biochim Biophys Acta 1302: 110–116, 1996
McArthur MJ, Atshaves BP, Frolov A, Foxworth WD, Kier AB, Schroeder F: Cellular uptake and intracellular trafficking of long chain fatty acids. J Lipid Res 40: 1371–183, 1999
Murphy EJ: Sterol carrier protein-2 expression increases NBD-stearate uptake and cytoplasmic diffusion in L cells. Am J Physiol 275: G237–243, 1998
Puglielli L, Rigotti A, Greco AV, Santos MJ, Nervi F: Sterol carrier protein-2 is involved in cholesterol transfer from the endoplasmic reticulum to the plasma membrane in human fibroblasts. J Biol Chem 270: 18723–18726, 1995
Gallegos AM, Atshaves BP, Storey SM, McIntosh AL, Petrescu AD, Schroeder F: Sterol carrier protein-2 expression alters plasma membrane lipid distribution and cholesterol dynamics. Biochemistry 40: 6493–6506, 2001
Murphy EJ, Schroeder F: Sterol carrier protein-2 mediated cholesterol esterification in transfected L-cell fibroblasts. Biochim Biophys Acta 1345: 283–292, 1997
Murphy EJ, Stiles T, Schroeder F: Sterol carrier protein-2 expression alters phospholipid content and fatty acyl composition in L-cell fibroblasts. J Lipid Res 41: 788–796, 2000
Schroeder F, Zhou M, Swaggerty CL, Atshaves BP, Petrescu AD, Storey SM, Martin GG, Huang H, Helmkamp GM, Ball JM: Sterol carrier protein-2 functions in phosphatidylinositol transfer and signaling. Biochemistry 42: 3189–3202, 2003
Marks DL, Dominguez M, Wu K, Pagano RE: Identification of active site residues in glucosylceramide synthase. A nucleotide-binding catalytic motif conserved with processive beta-glycosyltransferases. J Biol Chem 276: 26492–26498, 2001
Atshaves BP, Petrescu AD, Starodub O, Roths JB, Kier AB, Schroeder F: Expression and intracellular processing of the 58 kDa sterol carrier protein-2/3-oxoacyl-CoA thiolase in transfected mouse L-cell fibroblasts. J Lipid Res 40: 610–622, 1999
van Echten-Deckert G: Sphingolipid extraction and analysis by thin-layer chromatography. Methods Enzymol 312: 64–79, 2000
van Echten G, Iber H, Stotz H, Takatsuki A, Sandhoff K: Uncoupling of ganglioside biosynthesis by Brefeldin A. Eur J Cell Biol 51: 135–139, 1990
Schwarzmann G, Hofmann P, Putz U, Albrecht B: Demonstration of direct glycosylation of nondegradable glucosylceramide analogs in cultured cells. J Biol Chem 270: 21271–21276, 1995
Puri V, Jefferson JR, Singh RD, Wheatley CL, Marks DL, Pagano RE: Sphingolipid Storage induces accumulation of intracellular cholesterol by stimulating SREBP-1 cleavage. J Biol Chem 278: 20961–20970, 2003
Tietz P, Jefferson J, Pagano R, Larusso NF: Membrane microdomains in hepatocytes: Potential target areas for proteins involved in canalicular bile secretion. J Lipid Res 46: 1426–1432, 2005
Mazzone A: Isolation and characterization of lipid microdomains from apical and basolateral plasma membranes of hepatocyte. submitted to Hepatology, 2005
Atshaves BP, Gallegos AM, McIntosh AL, Kier AB, Schroeder F: Sterol carrier protein-2 selectively alters lipid composition and cholesterol dynamics of caveolae/lipid raft vs. nonraft domains in L-cell fibroblast plasma membranes. Biochemistry 42: 14583–14598, 2003
van der Luit AH, Budde M, Ruurs P, Verheij M, van Blitterswijk WJ: Alkyl-lysophospholipid accumulates in lipid rafts and induces apoptosis via raft-dependent endocytosis and inhibition of phosphatidylcholine synthesis. J Biol Chem 277: 39541–39547, 2002
Marks DL, Paul P, Kamisaka Y, Pagano RE: Methods for studying glucosylceramide synthase. Methods Enzymol 311: 50–59, 2000
Bligh EG, Dyer WJ: A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911–917, 1959
Puri V, Watanabe R, Singh RD, Dominguez M, Brown JC, Wheatley CL, Marks DL, Pagano RE: Clathrin-dependent and -independent internalization of plasma membrane sphingolipids initiates two Golgi targeting pathways. J Cell Biol 154: 535–547, 2001
Pagano RE, Watanabe R, Wheatley C, Dominguez M: Applications of BODIPY-sphingolipid analogs to study lipid traffic and metabolism in cells. Methods Enzymol 312: 523–534, 2000
Chen CS, Martin OC, Pagano RE: Changes in the spectral properties of a plasma membrane lipid analog during the first seconds of endocytosis in living cells. Biophys J 72: 37–50, 1997
Smart EJ: Scavenger receptors, caveolae, caveolin, and cholesterol trafficking. In: Freeman TYCaDA (ed) Intracellular cholesterol trafficking. Kluwer Academic Publishers, Boston, 1998, pp 253–272
Giudici ML, Vos JP, Marchesini S, Van Golde LM, Lopes-Cardozo M: Uptake and metabolism of fluorescent ceramide analogs by rat oligodendrocytes in culture. FEBS Lett 314: 471–476, 1992
Merrill AH, Jr, Jones DD: An update of the enzymology and regulation of sphingomyelin metabolism. Biochim Biophys Acta 1044: 1–12, 1990
Leppimaki P, Kronqvist R, Slotte JP: The rate of sphingomyelin synthesis de novo is influenced by the level of cholesterol in cultured human skin fibroblasts. Biochem J 335: 285–291, 1998
Voet D. aVJG: Biochemistry. Wiley, New York, 1995, pp. 717– 725
Devlin TM: Textbook of Biochemsitry. Wiley-Liss, New York, 1992, pp. 449–461
Ferlinz K, Linke T, Bartelsen O, Weiler M, Sandhoff K: Stimulation of lysosomal sphingomyelin degradation by sphingolipid activator proteins. Chem Phys Lipids 102: 35–43, 1999
Sadeghlar F, Remmel N, Breiden B, Klingenstein R, Schwarzmann G, Sandhoff K: Physiological relevance of sphingolipid activator proteins in cultured human fibroblasts. Biochimie 85: 439–448, 2003
Lloyd-Evans E, Pelled D, Riebeling C, Bodennec J, De-Morgan A, Waller H, Schiffmann R, Futerman AH: Glucosylceramide and glucosylsphingosine modulate calcium mobilization from brain microsomes via different mechanisms. J Biol Chem 278: 23594–23599, 2003
Hummel I, Klappe K, Kok JW: Up-regulation of lactosylceramide synthase in MDR1 overexpressing human liver tumour cells. FEBS Lett 579: 3381–3384, 2005
Yamamoto R, Kallen CB, Babalola GO, Rennert H, Billheimer JT, Strauss JF, 3rd: Cloning and expression of a cDNA encoding human sterol carrier protein 2. Proc Natl Acad Sci U S A 88: 463–467, 1991
Seedorf U, Assmann G: Cloning, expression, and nucleotide sequence of rat liver sterol carrier protein 2 cDNAs. J Biol Chem 266: 630–636, 1991
Keller GA, Scallen TJ, Clarke D, Maher PA, Krisans SK, Singer SJ: Subcellular localization of sterol carrier protein-2 in rat hepatocytes: Its primary localization to peroxisomes. J Cell Biol 108: 1353–1361, 1989
Kovacs WJ, Olivier LM, Krisans SK: Central role of peroxisomes in isoprenoid biosynthesis. Prog Lipid Res 41: 369–391, 2002
van der Klei I, Veenhuis M: Peroxisomes: Flexible and dynamic organelles. Curr Opin Cell Biol 14: 500–505, 2002
Saito M, Iwamori M, Lin B, Oka A, Fujiki Y, Shimozawa N, Kamoshita S, Yanagisawa M, Sakakihara Y: Accumulation of glycolipids in mutant Chinese hamster ovary cells (Z65) with defective peroxisomal assembly and comparison of the metabolic rate of glycosphingolipids between Z65 cells and wild-type CHO-K1 cells. Biochim Biophys Acta 1438: 55–62, 1999
Ardail D, Popa I, Bodennec J, Louisot P, Schmitt D, Portoukalian J: The mitochondria-associated endoplasmic-reticulum subcompartment (MAM fraction) of rat liver contains highly active sphingolipid-specific glycosyltransferases. Biochem J 371: 1013–1019, 2003
Author information
Authors and Affiliations
Corresponding author
Additional information
Portions of this work were presented in abstract at the 2004 annual meeting of the American Society of Biochemistry and Molecular Biology, Boston Mass FASEB J, 18(8): C271, 2004
Rights and permissions
About this article
Cite this article
Milis, D.G., Moore, M.K., Atshaves, B.P. et al. Sterol carrier protein-2 expression alters sphingolipid metabolism in transfected mouse L-cell fibroblasts. Mol Cell Biochem 283, 57–66 (2006). https://doi.org/10.1007/s11010-006-2270-1
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11010-006-2270-1